Dissection of the physiological interconversion of 5α-DHT and 3α-diol by rat 3α-HSD via transient kinetics shows that the chemical step is rate-determining:: Effect of mutating cofactor and substrate-binding pocket residues on catalysis

被引:22
作者
Heredia, VV
Penning, TM
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
关键词
D O I
10.1021/bi0489762
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3alpha-Hydroxysteroid dehydrogenases (3alpha-HSDs) catalyze the interconversion between 5alpha-dihydrotestosterone (5alpha-DHT), the most potent androgen, and Sot-androstanediol (3alpha-diol), a weak androgen metabolite. To identify the rate-determining step in this physiologically important reaction, rat liver 3alpha-HSD (AKR1C9) was used as the protein model for the human homologues in fluorescence stopped-flow transient kinetic and kinetic isotope effect studies. Using single and multiple turnover experiments to monitor the NADPH-dependent reduction of 5alpha-DHT, it was found that k(lim) and k(max) values were identical to k(cat), indicating that chemistry is rate-limiting overall. Kinetic isotope effect measurements, which gave (D)k(cat) = 2.4 and (D2O)k(cat) = 3.0 at pL 6.0, suggest that the slow chemical transformation is significantly rate-limiting. When the NADP(+)-dependent oxidation of 3alpha-diol was monitored, single and multiple turnover experiments showed a k(lim) and burst kinetics consistent with product release as being rate-limiting overall. When NAD(+) was substituted for NADP(+), burst phase kinetics was eliminated, and k(max) was identical to k(cat). Thus with the physiologically relevant substrates 5alpha-DHT plus NADPH and 3alpha-diol plus NAD(+), the slowest event is chemistry. R276 forms a salt-linkage with the phosphate of 2'-AMP, and when it is mutated, tight binding of NAD(P)H is no longer observed [Ratnam, K., et al. (1999) Biochemistry 38, 7856-7864]. The R276M mutant also eliminated the burst phase kinetics observed for the NADP(+)-dependent oxidation of 3alpha-diol. The data with the R276M mutant confirms that the release of the NADPH product is the slow event; and in its absence, chemistry becomes rate-limiting. W227 is a critical hydrophobic residue at the steroid binding site, and when it is mutated to alanine, k(cat)/K-m for oxidation is significantly depressed. Burst phase kinetics for the NADP(+)-dependent turnover of 3alpha-diol by W227A was also abolished. In the W227A mutant, the slow release of NADPH is no longer observed since the chemical transformation is now even slower. Thus, residues in the cofactor and steroid-binding site can alter the rate-determining step in the NADP(+)-dependent oxidation of Sot-diol to make chemistry rate-limiting overall.
引用
收藏
页码:12028 / 12037
页数:10
相关论文
共 44 条
[1]   THE KINETIC MECHANISM CATALYZED BY HOMOGENEOUS RAT-LIVER 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE - EVIDENCE FOR BINARY AND TERNARY DEAD-END COMPLEXES CONTAINING NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ASKONAS, LJ ;
RICIGLIANO, JW ;
PENNING, TM .
BIOCHEMICAL JOURNAL, 1991, 278 :835-841
[2]  
BEARD WA, 1989, J BIOL CHEM, V264, P9391
[3]   Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP [J].
Bennett, MJ ;
Schlegel, BP ;
Jez, JM ;
Penning, TM ;
Lewis, M .
BIOCHEMISTRY, 1996, 35 (33) :10702-10711
[4]   Steroid recognition and regulation of hormone action: Crystal structure of testosterone and NADP(+) bound to 3 alpha-hydroxysteroid dihydrodiol dehydrogenase [J].
Bennett, MJ ;
Albert, RH ;
Jez, JM ;
Ma, HC ;
Penning, TM ;
Lewis, M .
STRUCTURE, 1997, 5 (06) :799-812
[5]  
BOHREN KM, 1991, J BIOL CHEM, V266, P24031
[6]   Mechanism-based inhibition of human steroid 5 alpha-reductase by finasteride: Enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor [J].
Bull, HG ;
GarciaCalvo, M ;
Andersson, S ;
Baginsky, WF ;
Chan, HK ;
Ellsworth, DE ;
Miller, RR ;
Stearns, RA ;
Bakshi, RK ;
Rasmusson, GH ;
Tolman, RL ;
Myers, RW ;
Kozarich, JW ;
Harris, GS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (10) :2359-2365
[7]   REGULATION OF PROSTATE GROWTH [J].
DAVIES, P ;
EATON, CL .
JOURNAL OF ENDOCRINOLOGY, 1991, 131 (01) :5-17
[8]   MECHANISM OF ALDOSE REDUCTASE INHIBITION - BINDING OF NADP+/NADPH AND ALRESTATIN-LIKE INHIBITORS [J].
EHRIG, T ;
BOHREN, KM ;
PRENDERGAST, FG ;
GABBAY, KH .
BIOCHEMISTRY, 1994, 33 (23) :7157-7165
[9]   5 alpha-reductase inhibitors in prostate cancer [J].
Gormley, GJ .
ENDOCRINE-RELATED CANCER, 1996, 3 (01) :57-63
[10]  
Griffiths K, 1999, TEXTBOOK OF PROSTATE CANCER, P51